Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
Primary Efficacy Objective: To demonstrate the efficacy of MF/F 100/10 mcg twice daily, compared with MF 100 mcg twice daily, by evaluating lung function during the first 12 weeks of double-blind treatment in children ages 5–11 years with persistent asthma. Primary Safety Objective: To characterize the safety and tolerability of MF/F 100/10 mcg twice daily and MF 100 mcg twice daily based on adverse events reported in association with up to 24 weeks of treatment in children ages 5 to 11 years with persistent asthma.
Critère d'inclusion
- Asthma